Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theresa L Wampler Muskardin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
ACR Open Rheumatology|April 9, 2020
Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019Theresa L Wampler Muskardin
Nature Reviews. Rheumatology|March 22, 2018
Type I interferon in rheumatic diseasesTheresa L Wampler Muskardin, Timothy B Niewold
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2020
Lessons from precision medicine in rheumatologyTheresa L Wampler Muskardin, Jacqueline L Paredes, Simone Appenzeller, et al.
Annals of the Rheumatic Diseases|December 9, 2020
Anti-inflammatory therapy for COVID-19 infection: the case for colchicineAaron Z Reyes, Kelly A Hu, Jacob Teperman, et al.
Rheumatology International|August 20, 2020
Novel mutation in the NRLP3 manifesting as an intermediate phenotype of cryopyrinopathiesLuciana B Paim-Marques, Amanda Cavalcante, Catherine Castro, et al.
JCI Insight|August 18, 2017
Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonistMegha Garg, Adriana A de Jesus, Dawn Chapelle, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 3, 2022
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19Ilona Nln, Ruth Fernandez-Ruiz, Theresa L Wampler Muskardin, et al.
Medrxiv : the Preprint Server for Health Sciences|November 9, 2021
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19Ilona Nln, Ruth Fernandez-Ruiz, Theresa L Wampler Muskardin, et al.
ACR Open Rheumatology|November 29, 2019
Interferon Chemokine Score and Other Cytokine Measures Track With Changes in Disease Activity in Patients With Juvenile and Adult DermatomyositisCynthia S Crowson, Molly S Hein, Richard S Pendegraft, et al.
Arthritis Research & Therapy|September 28, 2017
Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: a comprehensive clinical evaluationDivya N Challa, Zoran Kvrgic, Andrea L Cheville, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
ACR Open Rheumatology|April 9, 2020
Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019Theresa L Wampler Muskardin
Nature Reviews. Rheumatology|March 22, 2018
Type I interferon in rheumatic diseasesTheresa L Wampler Muskardin, Timothy B Niewold
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2020
Lessons from precision medicine in rheumatologyTheresa L Wampler Muskardin, Jacqueline L Paredes, Simone Appenzeller, et al.
Annals of the Rheumatic Diseases|December 9, 2020
Anti-inflammatory therapy for COVID-19 infection: the case for colchicineAaron Z Reyes, Kelly A Hu, Jacob Teperman, et al.
Rheumatology International|August 20, 2020
Novel mutation in the NRLP3 manifesting as an intermediate phenotype of cryopyrinopathiesLuciana B Paim-Marques, Amanda Cavalcante, Catherine Castro, et al.
JCI Insight|August 18, 2017
Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonistMegha Garg, Adriana A de Jesus, Dawn Chapelle, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 3, 2022
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19Ilona Nln, Ruth Fernandez-Ruiz, Theresa L Wampler Muskardin, et al.
Medrxiv : the Preprint Server for Health Sciences|November 9, 2021
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19Ilona Nln, Ruth Fernandez-Ruiz, Theresa L Wampler Muskardin, et al.
ACR Open Rheumatology|November 29, 2019
Interferon Chemokine Score and Other Cytokine Measures Track With Changes in Disease Activity in Patients With Juvenile and Adult DermatomyositisCynthia S Crowson, Molly S Hein, Richard S Pendegraft, et al.
Arthritis Research & Therapy|September 28, 2017
Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: a comprehensive clinical evaluationDivya N Challa, Zoran Kvrgic, Andrea L Cheville, et al.
Pageof 2